Cancer-testis antigens: the current status on antigen regulation and potential clinical use.


Immunotherapy is theoretically an attractive therapeutic option for patients with hematological malignancies. Various laboratory studies suggested the importance of the choice of tumor antigen for successful immunotherapy. Cancer-testis antigens (CTAs) are potentially suitable molecules for tumor vaccines of hematological malignancies because of their high… (More)


2 Figures and Tables

Slides referencing similar topics